Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared biotechnology a national priority. Boosting biotech within Brazil has the potential to create high paying jobs and develop a healthier, more productive workforce.
This week BIO will be in Brazil for a roundtable meeting with representatives from Brazil’s National Committee on Biotechnology (or Comité Nacional de Biotecnologia (CNB)), representing close to a dozen relevant government agencies and ministries including the Ministry of Trade’s Innovation Secretariat, Ministry of Agriculture, Ministry of Health and Ministry of Science, Technology & Innovation.
BIO’s roundtable meeting is an opportunity for BIO to understand the role our organization and members can play in Brazil’s innovation agenda. The visit will also provide clarity on Brazil’s national industrial policy perspectives, from the current state of the biotechnology industry in Brazil to defining innovation in the Brazilian context and understanding what is in the development forecast.
From there, BIO will travel to Rio de Janeiro for a two-day Biotech Patent Examiner Workshop, which will be hosted by BIO at the request of Brazil’s national patent office, INPI.
The BIO - INPI Biotech Patent Examiner Workshop is a technical workshop that includes industry perspective and policy discussions. Participants will include 50 INPI biotech patent examiners and representative from other Brazilian agencies, including ANVISA and BNDES, the Brazilian National Development Bank. The Workshop agenda features an overview of the regulatory environment in Brazil as well as several panel sessions with a focus on industry perspective. Panel topics include: The Role of Patent Policy in Innovation; Leveraging Universities to Promote Innovation; Decision Making and Patent Strategy; Current Developments in Brazilian and U.S. Patent Law; Special Issues in Biotech Patenting and the Patent Process.
As a result of these meetings, BIO hopes to help lay the framework for policies that might integrate Brazilian industry into the global network of companies and researchers developing biotechnology.